Madison J M, Irwin R S
Pulmonary, Allergy, and Critical Care Medicine Division, University of Massachusetts Medical School, Worcester 01655, USA.
Lancet. 1998 Aug 8;352(9126):467-73. doi: 10.1016/S0140-6736(97)11081-9.
Acute exacerbations of underlying COPD are a common cause of respiratory deterioration. Developments have been made in preventive measures, but admission to hospital for acute exacerbations can be expected to remain common. Several expert consensus guidelines have been published to define the appropriate management of COPD patients. These consensus guidelines generally agree, but all acknowledge a lack of large well-controlled clinical studies, especially studies focusing on the management of acute exacerbations. Consequently, many potential controversies exist about the details of managing patients with acute exacerbations. Although studies of many fundamental aspects of management are still needed, the results of controlled clinical trials are sufficient to emphasise the importance of a careful clinical assessment, supplemental oxygen, inhaled bronchodilators to partially improve airway obstruction, corticosteroids to decrease the likelihood of treatment failures and to speed recovery, antibiotics, especially in severe patients, and non-invasive positive-pressure ventilation for treatment of acute ventilatory failure in selected patients.
慢性阻塞性肺疾病(COPD)的急性加重是导致呼吸功能恶化的常见原因。虽然在预防措施方面已取得进展,但因急性加重而住院的情况预计仍会很常见。已发布了若干专家共识指南来界定COPD患者的恰当管理方法。这些共识指南总体上意见一致,但都承认缺乏大型的严格对照临床研究,尤其是专注于急性加重管理的研究。因此,在急性加重患者管理细节方面存在许多潜在争议。尽管仍需要对管理的许多基本方面进行研究,但对照临床试验的结果足以强调仔细临床评估、补充氧气、吸入支气管扩张剂以部分改善气道阻塞、使用皮质类固醇以降低治疗失败可能性并加速康复、使用抗生素(尤其是重症患者)以及对选定患者使用无创正压通气治疗急性通气衰竭的重要性。